[go: up one dir, main page]

GB201604125D0 - Co-crystal - Google Patents

Co-crystal

Info

Publication number
GB201604125D0
GB201604125D0 GBGB1604125.3A GB201604125A GB201604125D0 GB 201604125 D0 GB201604125 D0 GB 201604125D0 GB 201604125 A GB201604125 A GB 201604125A GB 201604125 D0 GB201604125 D0 GB 201604125D0
Authority
GB
United Kingdom
Prior art keywords
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1604125.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita ta Malta UM
Original Assignee
Universita ta Malta UM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita ta Malta UM filed Critical Universita ta Malta UM
Priority to GBGB1604125.3A priority Critical patent/GB201604125D0/en
Publication of GB201604125D0 publication Critical patent/GB201604125D0/en
Priority to PCT/EP2017/055489 priority patent/WO2017153497A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
GBGB1604125.3A 2016-03-10 2016-03-10 Co-crystal Ceased GB201604125D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1604125.3A GB201604125D0 (en) 2016-03-10 2016-03-10 Co-crystal
PCT/EP2017/055489 WO2017153497A1 (en) 2016-03-10 2017-03-08 Increasing aqueous solubility of beclomethasone dipropionate by formation of co-crystals with co-crystal former

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1604125.3A GB201604125D0 (en) 2016-03-10 2016-03-10 Co-crystal

Publications (1)

Publication Number Publication Date
GB201604125D0 true GB201604125D0 (en) 2016-04-27

Family

ID=55952142

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1604125.3A Ceased GB201604125D0 (en) 2016-03-10 2016-03-10 Co-crystal

Country Status (2)

Country Link
GB (1) GB201604125D0 (en)
WO (1) WO2017153497A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2565803A (en) * 2017-08-23 2019-02-27 Univ Malta Valacyclovir co-crystal
US20230382944A1 (en) * 2022-05-26 2023-11-30 Versitech Limited Novel cocrystals of dexamethasone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07228525A (en) * 1994-02-18 1995-08-29 Pola Chem Ind Inc External preparation for skin
EP2167043A4 (en) * 2007-06-06 2013-05-01 Univ South Florida NUTRACEUTICAL COMPOSITIONS OF CO-CRISTAL
US10130713B2 (en) * 2013-04-19 2018-11-20 The Methodist Hospital Cocrystalline DHEA formulations
EP3080141A1 (en) * 2013-12-12 2016-10-19 Basf Se Solid form of abiraterone acetate

Also Published As

Publication number Publication date
WO2017153497A1 (en) 2017-09-14

Similar Documents

Publication Publication Date Title
IL261175B (en) Propyne-indole compounds
TWI561516B (en) Substituted dihydroisoquinolinone compounds
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
GB201602934D0 (en) Compounds
GB201620119D0 (en) Compounds
GB201619694D0 (en) Compounds
GB201604027D0 (en) Compounds
GB201604020D0 (en) Compounds
SI3464336T1 (en) Compounds
GB201610854D0 (en) Compounds
IL263228A (en) Benzoxaborole compounds
GB201608777D0 (en) Compounds
GB201613946D0 (en) Compounds
GB201604022D0 (en) Compounds
AP2017009778A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201604030D0 (en) Compounds
GB201713217D0 (en) Compounds
GB201621520D0 (en) Compounds
GB201604125D0 (en) Co-crystal
GB201622362D0 (en) Compounds
GB201604029D0 (en) Compounds
GB201622365D0 (en) Compounds
GB201604031D0 (en) Compounds
GB201720511D0 (en) Compounds
GB201622083D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)